Horsfall D J, Tilley W D, Orell S R, Marshall V R, Cant E L
Br J Cancer. 1986 Jan;53(1):23-8. doi: 10.1038/bjc.1986.4.
The relationship between ploidy, as measured by flow cytometry, and the presence of oestrogen and progesterone receptors was investigated in 145 primary invasive breast cancers. The tumours were considered as an integral group, and as subgroups of lobular and ductal carcinomas. An association was found between the presence of aneuploid stemlines and an absence of oestrogen receptors (ER), for the total tumour population (P less than 0.02), and for the ductal carcinoma group (P less than 0.05). An association between aneuploidy and an absence of progesterone receptors (PR) was observed for the total tumour group (P less than 0.05). Evaluation of a combined oestrogen and progesterone receptor status indicated that the association between aneuploidy and an absence of both receptors was highly significant. The probability of such an association was P less than 0.001 for the total tumour population, and P less than 0.01 for the ductal tumour group. Assessment of progesterone receptor expression by breast cancers containing oestrogen receptors indicated that aneuploid tumours were as likely to express PR as were diploid tumours. Hence, the biological activity of oestrogen receptors appears unmodified by the presence of aneuploid nuclei.
采用流式细胞术测定倍性,并研究其与145例原发性浸润性乳腺癌中雌激素和孕激素受体存在情况之间的关系。这些肿瘤被视为一个整体组,以及小叶癌和导管癌亚组。在整个肿瘤群体(P<0.02)和导管癌组(P<0.05)中,发现非整倍体干细胞系的存在与雌激素受体(ER)的缺失之间存在关联。在整个肿瘤组中观察到非整倍体与孕激素受体(PR)缺失之间的关联(P<0.05)。对雌激素和孕激素受体联合状态的评估表明,非整倍体与两种受体均缺失之间的关联非常显著。这种关联的概率在整个肿瘤群体中为P<0.001,在导管肿瘤组中为P<0.01。对含有雌激素受体的乳腺癌中孕激素受体表达的评估表明,非整倍体肿瘤与二倍体肿瘤表达PR的可能性相同。因此,雌激素受体的生物学活性似乎不受非整倍体细胞核存在的影响。